<DOC>
	<DOC>NCT00394472</DOC>
	<brief_summary>The purpose of this study is to estimate the effect of AZD3355 as an add-on treatment to a Proton Pump Inhibitor (PPI) on Gastroesophageal reflux disease (GERD) symptoms in patients with an incomplete response to PPI treatment.</brief_summary>
	<brief_title>Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Lesogaberan</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>Provision of written informed consent At least 6 months history of Gastroesophageal reflux disease (GERD) symptoms Continuous treatment with Proton Pump Inhibitor (PPI) Ability to read and write Prior surgery of the upper gastrointestinal (GI) tract History of clinically significant diseases other than GERD Need for concomitant medication with drugs that may influence gastrointestinal symptoms</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Heartburn</keyword>
	<keyword>Patient reported symptoms</keyword>
	<keyword>Proton pump inhibitor</keyword>
</DOC>